In the evolving field of targeted delivery systems, the dodecapeptide known as GE11 (YHWYGYTPQNVI) has become a cornerstone for researchers focused on the epidermal growth factor receptor (EGFR). As an enthusiast documenting my journey through biochemical reagents, I have frequently navigated the complexities of sourcing this specific ligand. Understanding the nuances of GE11 peptide sigma availability is essential for any laboratory or independent researcher looking to incorporate this molecule into their experimental workflows.
Und GE11-antigen-loaded hepatitis B virus core - PMC - NIH erstanding the GE11 Pep by WW Xu·2017·Cited by 47—In this study, dual therapeutic-loadedGE11 peptide-conjugated liposomes were developed and applied to enhance therapeutic efficacies of standard-of-care Read more tide Sequence and Function
The GE11 peptide was initially identified via phage display technology. It is a 12-amino-acid peptide that demonstrates a specific affinity for EGFR, with a dissociation constant (KD) reported at approximately 22 nM. Because GE11 is an active peptide, it has garnered significant interest for its potential as a targeting moiety. Unlike natural EGF, which can trigger receptor-mediated mitogenic s This Human Ghrelin (active) ELISA is used to measure & quantify Ghrelin (active) levels in Metabolism & Endocrine & Neuroscience research.Read more ignaling, the GE11 peptide sequence is often cited for its ability to bind the receptor without inducing the same level of internalization or proliferative s GE11 peptide conjugated selenium nanoparticles for EGFR ignaling, making it a "smart" candidate for drug carrier systems.
Research Applications and Material Integration
My experience with functionalized materials, such as DSPE-PEG2000-GE11, highlights the versatility of this ligand. Researchers often use this conjugate to stabilize nanoliposomes for targeted delivery. Furthermore, the development of GE11-C Peptides purchase SO-SPION micelles as an MRI contrast agent represents a sophisticated application for diagnostic imaging in high-EGFR-expression environments.
When discussing GE11-Se NPs (selenium nanoparticles), the focus shifts toward lo Targeted cancer treatment using a novel EGFR-specific Fc calized therapeutic delivery. The primary goal is to enhance the precision of antitumor studies. However, it is vital to acknowledge the technical challenges reported in recent literature: some studies suggest that GE11 exhibits an insufficient affinity to the EGFR when used as a monomer, leading to ongoing investigations into multivalent presentations or Fc-fusion constructs to improve binding stability.
Navigating Procurem Towards Radiolabeled EGFR-Specific Peptides ent and Sigma Peptides
For those looking to buy research peptides, the procurement process requires a clear understanding of institutional policies. If you are searching for Sigma Peptide or related catalog entries, you will likely find that these materials are strictly designated for Research Use Only (RUO).
1. Verification: Always confirm the catalog number (e.g., ABIN2874272 for synthetic variants) and the purity levels required for your specific assay.
2. Availability: While you may search for gd11 or other catalog codes, ensure you are distinguishing between the specific EGFR-targeting GE11 and other unrelated sequences that may appear in broader databases.
3. Documentation: Suppliers often require proof of affiliation with a research facility. The availability of peptides in bulk or custom synthesis formats is standard, but the lead time for custom modifications can vary.
E-E-A-T Considerations in Peptide Research
When utilizing these compounds, rigor Towards Radiolabeled EGFR-Specific Peptides is paramount. GE11 is studied as a peptide ligand across diverse platforms, from liposomes to radiotracers. As a researcher, I emphasize the importance of validating the binding affinity of your specific batch, as synthesis methods (such as ultrasound-assisted solid-phase synthesis) can influence the final efficacy. GE11 was identified as a potential EGFR-specific peptide over a decade ago, and while it remains a vital tool, the field is constantly refining how we utilize these sequences to avoid off-target effects.
Whether you are designing a new delivery system or testing the diagnostic potential of GE11, maintaining a clear chain of custody and adhering to the strict "Research Use Only" guidelines is critical. By focusing on the biochemical properties and the specific structural requirements of the EGFR-targeting mechanism, researchers can continue to push the boundaries of what is possible with these sophisticated molecular tools.